Perioperative Management of Cold Agglutinin Disease Using Central–Peripheral Temperature Monitoring: A Case Report
Case Reports in Anesthesiology · 2026-01 · 2026 (1)
DOI: 10.1155/cria/4064832 ↗Abstract
Cold agglutinin disease is characterised by temperature‐dependent immunoglobulin M–mediated complement activation and haemolysis. In severe disease, antibody activity may occur near physiologic temperatures. General anaesthesia impairs thermoregulation and promotes redistribution hypothermia, potentially exposing peripheral blood to temperatures associated with haemolysis. We describe the perioperative management of a 67‐year‐old man with high‐titre cold agglutinin disease undergoing right thyroid lobectomy. Because of baseline anaemia and anticipated transfusion constraints, a structured thermal management strategy was implemented. This included active prewarming before arrival in the operating room, ambient temperature control at 23°C, warmed intravenous fluids and continuous central and peripheral temperature monitoring. Core temperature remained between 37.2°C and 38.1°C throughout the procedure, while the central–peripheral temperature gradient was maintained at 0.4°C or less. No intraoperative hypothermia occurred, and haemodynamic stability was preserved without vasopressor support. Postoperative haemoglobin concentration remained unchanged at 8.8 g·dL −1 , with no clinical evidence of haemolysis. This case suggests that perioperative management in cold agglutinin disease should focus not only on preventing overt hypothermia but also on limiting redistribution‐induced peripheral cooling. The combination of prewarming, environmental temperature control and dual‐site temperature monitoring was associated with thermal stability and an uncomplicated perioperative course.
EUVIMED